[8-K] Dragonfly Energy Holdings Corp. Reports Material Event

Rhea-AI Filing Summary

Dragonfly Energy Holdings Corp. entered an underwriting agreement to sell 20,000,000 shares of its common stock at a public offering price of $1.25 per share and granted the underwriters a 30‑day option for up to 3,000,000 additional shares at the same price. The underwriters fully exercised that option, increasing the total shares offered to 23,000,000. All shares are being sold by the company rather than existing holders.

The filing notes standard representations, warranties and termination provisions in the underwriting agreement and includes legal opinions and a pricing press release as exhibits. The document discloses the offering size and price, the exercise of the option in full, and attendant legal and disclosure exhibits; it does not provide proceeds, use of proceeds, or underwriting fees in the disclosed text.

Positive

• Underwriting fully subscribed: the underwriters exercised the full 30‑day option for an additional 3,000,000 shares
• Equity raise executed via underwritten offering: sale of 23,000,000 shares provides a clear capital‑raising mechanism

Negative

• Dilution to existing shareholders: issuance of 23,000,000 new shares will increase share count
• Offering price is relatively low at $1.25 per share compared with prior trading ranges if higher (investors may view as weakness)

Insights

Equity Capital Markets Analyst

Company completed a dilutive underwritten equity offering with the overallotment fully exercised.

The company sold 20,000,000 base shares at $1.25 per share and the underwriters exercised the 30‑day option for an additional 3,000,000 shares, bringing the Offering to 23,000,000 shares. This structure is a standard firm commitment underwriting where the issuer sells new shares to raise capital.

The primary dependency is how the company will use net proceeds and the market's reception to increased share supply; those details are not disclosed here. Monitor forthcoming disclosures for use of proceeds, underwriting discounts, and any forward‑looking capital allocation that could materially affect liquidity or dilution over the next quarter.

false 0001847986 0001847986 2025-10-06 2025-10-06 0001847986 DFLI:CommonStockParValue0.0001PerShareMember 2025-10-06 2025-10-06 0001847986 DFLI:RedeemableWarrantsExercisableForCommonStockMember 2025-10-06 2025-10-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 6, 2025

DRAGONFLY ENERGY HOLDINGS CORP.

(Exact name of registrant as specified in its charter)

Nevada		001-40730		85-1873463
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

12915 Old Virginia Road Reno, Nevada		89521
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (775) 622-3448

N/A

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.0001 per share		DFLI		The Nasdaq Capital Market
Redeemable warrants, exercisable for common stock		DFLIW		The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01 Entry into a Material Definitive Agreement.

On October 6, 2025, Dragonfly Energy Holdings Corp. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Canaccord Genuity LLC, as representative of the several underwriters named therein (the “Underwriters”), relating to an underwritten offering (the “Offering”) of 20,000,000 shares (the “Base Shares”) of the Company’s common stock, par value $0.0001 (the “Common Stock”), at a price to the public of $1.25 per share. Pursuant to the terms of the Underwriting Agreement, the Company granted to the Underwriters a 30-day option to purchase up to an additional 3,000,000 shares of Common Stock in the Offering (the “Option Shares” and together with the Base Shares, the “Shares”) at the public offering price. All of the Shares in the Offering are being sold by the Company. On October 6, 2025, the Underwriters exercised the option to purchase additional shares in full.

The net proceeds to the Company from the Offering (giving effect to the exercise of the Underwriters’ option) are expected to be approximately $26.7 million, after deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company. The Offering is expected to close on or about October 7, 2025, subject to customary closing conditions. The Company intends to use the net proceeds from the Offering for working capital and other general corporate purposes, including the prepayment of $4.0 million under its Term Loan, Guarantee and Security Agreement, dated October 7, 2022, with ALTER DOMUS (US) LLC, as agent, and certain lenders, continued investments in initiatives intended to drive near term revenue, and continued strategic investment in next generation battery technologies, including scaling the dry electrode process and its application to solid-state batteries.

The Shares are being offered and sold pursuant to a prospectus supplement, dated October 6, 2025 (the “Prospectus Supplement”), filed with the Securities and Exchange Commission (“SEC”) on October 6, 2025, and an accompanying base prospectus that forms a part of the Company’s Registration Statement on Form S-3 (File No. 333-275559), which was previously filed with the SEC on November 15, 2023 and declared effective on November 24, 2023.

Pursuant to the terms of the Underwriting Agreement, the Company has agreed to certain restrictions on the issuance and sale of its Common Stock and securities convertible into shares of Common Stock during the 90 day period following the date of the Underwriting Agreement.

The Underwriting Agreement contains customary representations, warranties and covenants of the Company, conditions to closing, and indemnification obligations of the Company and the Underwriters, including for liabilities under the Securities Act of 1933, as amended (the “Securities Act”), other obligations of the parties and termination provisions. The representations, warranties and covenants contained in the Underwriting Agreement were made only for purposes of such agreement and as of specific dates, were solely for the benefit of the parties to such agreement, and may be subject to limitations agreed upon by the contracting parties.

The foregoing description of the Underwriting Agreement is not complete and is qualified in its entirety by reference to the full text of the Underwriting Agreement, a copy of which is filed as Exhibit 1.1 to this Current Report on Form 8-K and is incorporated herein by reference. A copy of the opinion of Parsons Behle & Latimer relating to the legality of the issuance and sale of the Shares in the Offering is filed as Exhibit 5.1 to this Current Report on Form 8-K and incorporated herein by reference.

Item 7.01. Regulation FD Disclosure.

On October 6, 2025, the Company issued a press release announcing that it had priced the Offering (the “Pricing Press Release”). A copy of the Pricing Press Release is furnished hereto as Exhibit 99.1.

The information in this Current Report on Form 8-K under Item 7.01, including the information contained in Exhibit 99.1, is being furnished to the SEC and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by a specific reference in such filing.

Forward-Looking Statements

This Current Report on Form 8-K contains forward-looking statements that involve estimates, assumptions, risks and uncertainties. Forward-looking statements include, but are not limited to, statements related to the amount of proceeds expected from the Offering, the intended use of proceeds from the Offering and the timing and certainty of completion of the Offering. The risks and uncertainties relating to the Company and the Offering include general market conditions, the Company’s ability to complete the Offering on favorable terms, or at all, as well as other risks detailed from time to time in the Company’s filings with the SEC, including in its Annual Report on Form 10-K for the year ended December 31, 2024 and the Prospectus Supplement. These documents contain important factors that could cause actual results to differ from current expectations and from the forward-looking statements contained in this Current Report on Form 8-K. These forward-looking statements speak only as of the date of this Current Report on Form 8-K and the Company undertakes no obligation to publicly update any forward-looking statements to reflect new information, events or circumstances after the date of this Current Report on Form 8-K.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Description
1.1		Underwriting Agreement, dated October 6, 2025, by and between Dragonfly Energy Holdings Corp. and Canaccord Genuity LLC
5.1		Opinion of Parsons, Behle & Latimer.
23.1		Consent of Parsons Behle & Latimer (contained in Exhibit 5.1)
99.1		Press Release dated October 6, 2025
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	DRAGONFLY ENERGY HOLDINGS CORP.
Dated: October 6, 2025	By:	/s/ Denis Phares
	Name:	Denis Phares
	Title:	Chief Executive Officer, Interim Chief Financial Officer and President

FAQ

What did Dragonfly Energy (DFLI) announce in the 8‑K?

The company entered an underwriting agreement to sell 20,000,000 base shares at $1.25 per share and the underwriters exercised an option for an additional 3,000,000 shares, totaling 23,000,000 shares.

How many additional shares were provided by the underwriters' option for DFLI?

A 30‑day option allowed purchase of up to 3,000,000 additional shares, and that option was exercised in full.

Who is leading the offering for DFLI?

The underwriting agreement names Canaccord Genuity LLC as the representative of the several underwriters.

Are the shares sold by existing holders or the company for DFLI?

All of the shares in the Offering are being sold by the company, not by existing shareholders.

Does the 8‑K disclose how Dragonfly will use the proceeds?

The disclosed text does not state the intended use of proceeds, underwriting discounts, or net proceeds.